163 related articles for article (PubMed ID: 22972415)
1. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR.
Kim TJ; Lee YS; Kang JH; Kim YS; Kang CS
J Surg Oncol; 2011 Jan; 103(1):46-52. PubMed ID: 21031415
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study comparing anti-EGFR monoclonal antibody plus cisplatin-based chemoradiotherapy versus chemoradiotherapy alone for stage II-IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression.
Mao L; Tan J; Wang F; Luo Y; Liu W; Zeng F; Yu B; Huang H; Lu J; Peng X; Liu X
Clin Otolaryngol; 2019 Jul; 44(4):572-580. PubMed ID: 30972891
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.
Sun W; Long G; Wang J; Mei Q; Liu D; Hu G
Head Neck; 2014 Oct; 36(10):1508-16. PubMed ID: 23996630
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.
Chan CM; Ma BB; Hui EP; Wong SC; Mo FK; Leung SF; Kam MK; Chan AT
Oral Oncol; 2007 Apr; 43(4):373-8. PubMed ID: 16979927
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.
Soo R; Putti T; Tao Q; Goh BC; Lee KH; Kwok-Seng L; Tan L; Hsieh WS
Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):147-52. PubMed ID: 15723947
[TBL] [Abstract][Full Text] [Related]
10. Correlations between expression of epidermal growth factor receptor (EGFR), phosphorylated EGFR, cyclooxygenase-2 and clinicopathological variables and treatment outcomes in nasopharyngeal carcinomas.
Huang TL; Li CF; Huang HY; Fang FM
Chang Gung Med J; 2010; 33(6):619-27. PubMed ID: 21199607
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of epidermal growth factor receptor and type 1 insulin-like growth factor receptor in nasopharyngeal carcinoma.
Yuan Y; Zhou X; Song J; Qiu X; Li J; Ye L; Meng X; Xia D
Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):192-200. PubMed ID: 18444479
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
13. [Expression and correlation of cyclooxygenase-2 and vascular endothelial growth factor in nasopharyngeal carcinoma-].
Bai W; Hu B; Tang J; Li X; Huang R; Yu J; Gu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 26(9):408-10. PubMed ID: 22803408
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes.
Fang FM; Li CF; Chien CY; Rau KM; Huang HY
Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):447-55. PubMed ID: 17208308
[TBL] [Abstract][Full Text] [Related]
16. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.
Zhang JX; Cai MB; Wang XP; Duan LP; Shao Q; Tong ZT; Liao DZ; Li YY; Huang MY; Zeng YX; Shao JY
Med Oncol; 2013 Mar; 30(1):390. PubMed ID: 23275120
[TBL] [Abstract][Full Text] [Related]
17. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy.
Kim YJ; Go H; Wu HG; Jeon YK; Park SW; Lee SH
Head Neck; 2011 Oct; 33(10):1458-66. PubMed ID: 21928418
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of epidermal growth factor receptor activation to metastasis-free survival of nasopharyngeal carcinoma patients].
Yuan TZ; Li XX; Cao Y; Qian CN; Zeng MS; Guo X
Ai Zheng; 2008 May; 27(5):449-54. PubMed ID: 18479591
[TBL] [Abstract][Full Text] [Related]
20. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
